You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Avelumab

Showing 251 - 262 of 262
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Head Neck Cancer Trial in Kuwait (Pembrolizumab)

Recruiting
  • Locally Advanced Head and Neck Cancer
  • Kuwait, Kuwait
    Kuwait Cancer Control Center
Apr 13, 2021

Ovarian Cancer Stage IV Trial in France (Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab, Chemotherapy -

Active, not recruiting
  • Ovarian Cancer Stage IV
  • Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
  • Chemotherapy - Bevacizumab
  • Avignon, France
  • +16 more
Feb 15, 2022

Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Pembrolizumab (200mg)
  • +2 more
  • (no location specified)
Sep 18, 2023

Sintilimab, Cetuximab, Regorafenib,Combine,mCRC Trial (Sintilimab,regofinib,cetuximab)

Not yet recruiting
  • Sintilimab, Cetuximab, Regorafenib,Combine,mCRC
  • (no location specified)
Feb 8, 2021

Hepatobiliary Tumor, Liver Tumor, Biliary Tract Tumors Trial in Beijing (axitinib plus toripalimab)

Recruiting
  • Hepatobiliary Neoplasm
  • +2 more
  • axitinib plus toripalimab
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Aug 17, 2021

CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term

Completed
  • Paraneoplastic Syndromes
  • This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
  • Lyon, France
    Centre de référence des syndromes neurologiques paranéoplasiques
Jul 11, 2023

Solid Tumors, Mycosis Fungoides, Melanoma Trial in United States (TTI-621 Monotherapy, TTI-621 + PD-1/PD-L1 Inhibitor, TTI-621 +

Terminated
  • Solid Tumors
  • +7 more
  • TTI-621 Monotherapy
  • +4 more
  • Duarte, California
  • +6 more
May 13, 2020

Myocarditis, Cardiac Complication Trial in Paris (ICI)

Completed
  • Myocarditis
  • Cardiac Complication
  • Paris, France
    AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Sep 24, 2019

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Nivolumab, Cisplatin, Paclitaxel)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, China
    180 Fenglin Road
Jun 12, 2022

Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction

Completed
  • Arthritis
  • +7 more
  • Immune checkpoint inhibitor
  • Paris, France
    AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Sep 24, 2019

Gestational Trophoblastic Neoplasia Trial in Seongnam-si (Pembrolizumab Injection [Keytruda])

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Pembrolizumab Injection [Keytruda]
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Mar 10, 2020

Gastric Cancer Trial in Seoul (MCS110/PDR001 combination)

Unknown status
  • Gastric Cancer
  • MCS110/PDR001 combination
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 8, 2019